Literature DB >> 15449931

Thermodynamic and biophysical characterization of cytochrome P450 BioI from Bacillus subtilis.

Rachel J Lawson1, David Leys, Michael J Sutcliffe, Carol A Kemp, Myles R Cheesman, Susan J Smith, John Clarkson, W Ewen Smith, Ihtshamul Haq, John B Perkins, Andrew W Munro.   

Abstract

Cytochrome P450 BioI (CYP107H1) from Bacillus subtilis is involved in the early stages of biotin synthesis. Previous studies have indicated that BioI can hydroxylate fatty acids and may also perform an acyl bond cleavage reaction [Green, A. J., Rivers, S. L., Cheesman, M., Reid, G. A., Quaroni, L. G., Macdonald, I. D. G., Chapman, S. K., and Munro, A. W. (2001) J. Biol. Inorg. Chem. 6, 523-533. Stok, J. E., and De Voss, J. J. (2000) Arch. Biochem. Biophys. 384, 351-360]. Here we show novel binding features of P450 BioI--specifically that it binds steroids (including testosterone and progesterone) and polycyclic azole drugs with similar affinity to that for fatty acids (K(d) values in the range 0.1-160 microM). Sigmoidal binding curves for titration of BioI with azole drugs suggests a cooperative process in this case. BioI as isolated from Escherichia coli is in a mixed heme iron spin state. Alteration of the pH of the buffer system affects the heme iron spin-state equilibrium (higher pH increasing the low-spin content). Steroids containing a carbonyl group at the C(3) position induce a shift in heme iron spin-state equilibrium toward the low-spin form, whereas fatty acids produce a shift toward the high-spin form. Electron paramagnetic resonance (EPR) studies confirm the heme iron spin-state perturbation inferred from optical titrations with steroids and fatty acids. Potentiometric studies demonstrate that the heme iron reduction potential becomes progressively more positive as the proportion of high-spin heme iron increases (potential for low-spin BioI = -330 +/- 1 mV; for BioI as purified from E. coli (mixed-spin) = 228 +/- 2 mV; for palmitoleic acid-bound BioI = -199 +/- 2 mV). Extraction of bound substrate-like molecule from purified BioI indicates palmitic acid to be bound. Differential scanning calorimetry studies indicate that the BioI protein structure is stabilized by binding of steroids and bulky azole drugs, a result confirmed by resonance Raman studies and by analysis of disruption of BioI secondary and tertiary structure by the chaotrope guanidinium chloride. Molecular modeling of the BioI structure indicates that a disulfide bond is present between Cys250 and Cys275. Calorimetry shows that structural stability of the protein was altered by addition of the reductant dithiothreitol, suggesting that the disulfide is important to integrity of BioI structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449931     DOI: 10.1021/bi049132l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

2.  CYP153A6, a soluble P450 oxygenase catalyzing terminal-alkane hydroxylation.

Authors:  Enrico G Funhoff; Ulrich Bauer; Inés García-Rubio; Bernard Witholt; Jan B van Beilen
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

Review 3.  Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Authors:  Piotr J Mak; Ilia G Denisov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-06-28       Impact factor: 3.036

4.  Unusual spectroscopic and ligand binding properties of the cytochrome P450-flavodoxin fusion enzyme XplA.

Authors:  Soi H Bui; Kirsty J McLean; Myles R Cheesman; Justin M Bradley; Stephen E J Rigby; Colin W Levy; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

Review 5.  Spectroscopic features of cytochrome P450 reaction intermediates.

Authors:  Abhinav Luthra; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2010-12-16       Impact factor: 4.013

6.  Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Authors:  Kirsty J McLean; Paul Carroll; D Geraint Lewis; Adrian J Dunford; Harriet E Seward; Rajasekhar Neeli; Myles R Cheesman; Laurent Marsollier; Philip Douglas; W Ewen Smith; Ida Rosenkrands; Stewart T Cole; David Leys; Tanya Parish; Andrew W Munro
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

7.  Characterization of CalE10, the N-oxidase involved in calicheamicin hydroxyaminosugar formation.

Authors:  Heather D Johnson; Jon S Thorson
Journal:  J Am Chem Soc       Date:  2008-12-31       Impact factor: 15.419

8.  Development of biotin-prototrophic and -hyperauxotrophic Corynebacterium glutamicum strains.

Authors:  Masato Ikeda; Aya Miyamoto; Sumire Mutoh; Yuko Kitano; Mei Tajima; Daisuke Shirakura; Manami Takasaki; Satoshi Mitsuhashi; Seiki Takeno
Journal:  Appl Environ Microbiol       Date:  2013-05-24       Impact factor: 4.792

9.  Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450(BioI) ACP complex.

Authors:  Max J Cryle; Ilme Schlichting
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-06       Impact factor: 11.205

Review 10.  Cooperative properties of cytochromes P450.

Authors:  Ilia G Denisov; Daniel J Frank; Stephen G Sligar
Journal:  Pharmacol Ther       Date:  2009-06-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.